Generic Oncology Drugs Market Scope And Analysis

  • Report Code : TIPRE00006393
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Generic Oncology Drugs Market Scope, Size, and Share by 2031

Buy Now

Generic Oncology Drugs Market Report Generic Oncology Drugs Market Size and Share Generic Oncology Drugs Market Scope and Analysis

Generic Oncology Drugs Market Report Scope

Report Attribute Details
Market size in 2022 US$ 24.78 Billion
Market Size by 2031 US$ 42.43 Billion
Global CAGR (2023 - 2031) 6.3%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Molecular Type
  • Large Molecule
  • Small Molecule
By Indication
  • Lung Cancer
  • Stomach Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Prostate Cancer
  • Liver Cancer
  • Kidney Cancer
  • Cervical Cancer
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Teva Pharmaceutical Industries LTD
  • Sandoz International GMBH
  • Glenmark Pharmaceuticals LIMITED
  • Sun Pharmaceutical Industries LTD
  • MSN Laboratories
  • Aurobindo Pharma
  • Intas Pharmaceuticals LTD
  • Zydus Cadila
  • Mylan N V
  • Shilpa Medicare LTD